Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, in Healthy Adults Aged 18 Years and Above
Clinical trial NCT01879553 · COMPLETED
Trial details
- NCT number
- NCT01879553
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2013-08-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.